The veterinary diagnostics market is estimated to reach $x.xx billion by 2023 at a CAGR of x.xx%.
The Europe Veterinary Diagnostics Market has seen an exemplar shift in the past few years with the emergence of new and technologically advanced products, which had an optimistic impact on the overall growth of the market. Diagnostics provide tools for effective and rapid testing to undertake preventative or remedial measures for the health of the animal population. For instance, Food animal diagnostics assist in livestock and production animal preventive care and complement other measures such as vaccination and selective breeding. Similarly, lateral flow and other rapid tests are used in veterinary medicine to test commercial livestock (large animals - cows, poultry, sheep, pigs, etc.) and household pets (cats, dogs, etc.) to test for the presence of a variety of medical conditions caused by bacteria, viruses, allergies, and fertility issues.
Immunodiagnostics is the segment with the highest growth owing to the increase in the number of foodborne diseases affecting the animals and the need to perform various tests has increased gradually. In retrospect, the market for Molecular diagnostics is also expected to grow at a higher rate. An increase in purchase and usage of various diagnostic instruments that are utilized in veterinary practices, in-clinic diagnostic procedures, high-income households that keep pets and regularly visit veterinary laboratories are propelling the growth of this market. However, increasing the adoption of vegetarian food due to changing food habits, the economic downturn, the increasing risk of obesity, exposure to global cuisines, and other diseases are some of the factors affecting the growth.
The veterinary diagnostics market is mainly categorized by-product into clinical chemistry, molecular diagnostics, hematology analyzers, diagnostic imaging, immunodiagnostics, and others. By animal, type market covers companion animals and food-producing animals. Furthermore, on the basis of geography, the European Market is segmented into various regions namely, UK, Spain, Italy, Germany, and France.
The European Parliament and the Council adopted the Regulation on transmissible animal diseases (“Animal Health Law”) in March 2016. The Regulation will be applicable in the next 5 years and it’ll support the EU livestock sector in its quest towards competitiveness and safe and smooth EU market of animals and of their products, creating growth for the veterinary diagnostics market. Veterinary diagnostic products are as complex as they are difficult to manufacture. Many of the poultry and livestock diagnostic products are biologic products that demand materials from living organisms. Market development for companion animal diagnostic has depended heavily upon the purchasing and usage of in-clinic analyzers or diagnostic instruments used at veterinary practices.
Prominent companies playing an active role in the Europe Veterinary Diagnostics Market
This research report segmented and sub-segmented into the following categories:
By Product: Clinical Chemistry, Molecular Diagnostics, Haematology, Diagnostic Imaging, Immunodiagnostic
By Animals: Companion Animals, Food-Producing Animals
By Country: U.K, Spain, Germany, Italy, France
For more details click here
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product
5.1.1 Clinical Chemistry
5.1.1.1 Urine Analysis
5.1.1.2 Glucose Monitoring
5.1.1.3 Blood Gas Electrolyte Analysis
5.1.2 Molecular Diagnostics
5.1.2.1 Micro Arrays
5.1.2.2 PCR Tests
5.1.2.3 Other Molecular Diagnostics Tests
5.1.3 Haemotology
5.1.3.1 Haemotology Analysers
5.1.3.2 Haemotology Catridges
5.1.4 Diagnostic Imaging
5.1.4.1 Radiography Systems
5.1.4.2 Ultrasound Imaging Systems
5.1.4.3 CT Scanners
5.1.4.4 MRI Scanners
5.1.5 Immunodiagnostics
5.1.5.1 Immunoassay Analysers
5.1.5.2 ELISA Tests
5.1.5.3 Lateral-Flow Strip Readers
5.1.5.4 Lateral-Flow Rapid Tests
5.1.5.5 Allergen specific Immunodiagnostic Tests
5.2 By Animals
5.2.1 Companion Animals
5.2.1.1 Canine Diagnostics
5.2.1.2 Feline Diagnostics
5.2.1.3 Other Veterinary Diagnostics
5.2.2 Food-Producing Animals
5.2.2.1 Bovine Diagnostics
5.2.2.2 Porcine Diagnostics
5.2.2.3 Ovine Diagnostics
5.2.2.4 Poultry Diagnostics
5.2.2.5 Piscine Diagnostics
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Abaxis Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Heska Corporation
8.3 VCA Inc.
8.4 IDEXX Laboratories
8.5 Life Technologies Corporation
8.6 Bio-Rad Laboratories Inc.
8.7 Prionics AG
8.8 Pfizer Inc.
8.9 VIRBAC
8.10 Zoetis Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
